EUVIMEDEUVIMED entdecken
Crossref

Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial

James Bell iD, Thomas Drury iD, Tobias Mütze iD, Christian Bressen Pipper iD, Lorenzo Guizzaro iD, Marian Mitroiu iD, Khadija Rerhou Rantell iD, Marcel Wolbers iD, David Wright iD

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.2472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von James Bell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Clinical Data Sciences, Elderbrook Solutions GmbH, Buckinghamshire, UK. Hauptthemen laut MEDLINE: Computer Simulation, Clinical Trials, Phase III as Topic, Models, Statistical. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estimands using the treatment policy strategy for addressing intercurrent events are common in Phase III clinical trials. One estimation approach for this strategy is retrieved dropout whereby observed data following an intercurrent event are used to multiply impute missing data. However, such methods have had issues with variance inflation and model fitting due to data sparsity. This paper introduces likelihood‐based versions of these approaches, investigating and comparing their statistical properties to the existing retrieved dropout approaches, simpler analysis models and reference‐based multiple imputation. We use a simulation based upon the data from the PIONEER 1 Phase III clinical trial in Type II diabetics to present complex and relevant estimation challenges. The likelihood‐based methods display similar statistical properties to their multiple imputation equivalents, but all retrieved dropout approaches suffer from high variance. Retrieved dropout approaches appear less biased than reference‐based approaches, resulting in a bias‐variance trade‐off, but we conclude that the large degree of variance inflation is often more problematic than the bias. Therefore, only the simpler retrieved dropout models appear appropriate as a primary analysis in a clinical trial, and only where it is believed most data following intercurrent events will be observed. The jump‐to‐reference approach may represent a more promising estimation approach for symptomatic treatments due to its relatively high power and ability to fit in the presence of much missing data, despite its strong assumptions and tendency toward conservative bias. More research is needed to further develop how to estimate the treatment effect for a treatment policy strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computer SimulationClinical Trials, Phase III as TopicModels, StatisticalHumansPatient DropoutsResearch DesignDiabetes Mellitus, Type 2Data Interpretation, StatisticalLikelihood FunctionsBias

Stichwörter der Autor:innen

estimandestimationintercurrent eventmultiple imputationreference‐based imputationretrieved dropoutsimulation studytreatment policy

Autor:innen und Institutionen

  • Biostatistics and Clinical Data Sciences, Elderbrook Solutions GmbH, Buckinghamshire, UK.
  • Statistics & Data Science Innovation Hub, GlaxoSmithKline, London, UK.
  • Advanced Quantitative Sciences, Novartis Pharma AG, Basel, Switzerland.
  • Methods and Outreach, Biostatistics, Novo Nordisk A/S, Soeborg, Denmark & Dept. of Public Health, University of Southern Denmark, Odense, Denmark.
  • Human Medicines, European Medicines Agency, Domenico Scarlattilaan 6, Amsterdam, The Netherlands.
  • Biostatistics, Quantitative Sciences & Development Operations, Biogen International GmbH, Baar, Zug, Switzerland.

ORCID-Profile: James Bell, Thomas Drury, Tobias Mütze, Christian Bressen Pipper, Lorenzo Guizzaro, Marian Mitroiu, Khadija Rerhou Rantell, Marcel Wolbers, David Wright

Zitieren

APA

Bell, J., Drury, T., Mütze, T., Pipper, C. B., Guizzaro, L., Mitroiu, M., Rantell, K. R., Wolbers, M., & Wright, D. (2025). Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2472

Vancouver

Bell J, Drury T, Mütze T, Pipper CB, Guizzaro L, Mitroiu M, et al. Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2472

BibTeX
@article{Bell2025,
  author = {Bell, James and Drury, Thomas and Mütze, Tobias and Pipper, Christian Bressen and Guizzaro, Lorenzo and Mitroiu, Marian and Rantell, Khadija Rerhou and Wolbers, Marcel and Wright, David},
  title = {Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.2472}
}
Kostenlos starten →